Acelyrin, Inc.
SLRN
$2.09
-$0.39-15.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -37.63% | 145.64% | 307.22% | 501.13% | 674.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -50.20% | 212.20% | 454.27% | 563.58% | 751.86% |
| Operating Income | 50.20% | -212.20% | -454.27% | -563.58% | -751.86% |
| Income Before Tax | 34.96% | 13.66% | -26.66% | -6.67% | -489.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.96% | 13.66% | -26.66% | -6.67% | -489.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.96% | 13.66% | -26.66% | -6.67% | -489.21% |
| EBIT | 50.20% | -212.20% | -454.27% | -563.58% | -751.86% |
| EBITDA | 46.46% | -359.43% | -1,493.81% | -- | -- |
| EPS Basic | 77.00% | 86.54% | 88.75% | 92.77% | 76.00% |
| Normalized Basic EPS | 67.66% | 53.71% | 67.80% | 79.00% | 83.84% |
| EPS Diluted | 77.00% | 86.54% | 88.75% | 92.77% | 76.00% |
| Normalized Diluted EPS | 67.66% | 53.71% | 67.80% | 79.00% | 83.84% |
| Average Basic Shares Outstanding | 41.77% | 113.77% | 337.78% | 1,285.25% | 4,403.73% |
| Average Diluted Shares Outstanding | 41.77% | 113.77% | 337.78% | 1,285.25% | 4,403.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |